fashion -WSS

fashion

author：focus 2025-09-02 08:10:44 - browse：93397

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

WSS

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Amylyx ALS drug failure raises questions and concerns

Readout LOUD: Venture capital, Gilead, and more M&A

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

AI gets buy

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

focus

fashion

focus

Dobbs anniversary: the lost opportunity of abortion as health care

AI gets buy

23andMe had bad news about my health. I wish a person had delivered it

Global cancer cases to surge 77% by 2050, WHO report says

Anesthesiologist group: stop taking Ozempic before surgery

Sen. Paul opposes bill to ban Chinese biotechs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Gene therapy for Afghan refugees’ infant will be fully covered

Alkermes shareholders re

Devoted Health’s losses in Medicare Advantage persist

focus

The Biogen Aduhelm mess could happen again

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Sen. Paul opposes bill to ban Chinese biotechs

With psoriasis trial ahead, Alumis raises $259 million

Novo Nordisk obesity pill bests Wegovy in early trial

Change Healthcare payments predicted restored March 15

focus

focus

focus

leisure time